FoRx Therapeutics
Series AFoRx Therapeutics raised €43M in a Series A round in Dec 2025. The company is based in Basel, Switzerland. Investors in the round: EQT Life Sciences, M Ventures, Novartis Venture Fund and 1 other. Data as of Nov 2026.
Amount raised
€43M
€42,691,257
Native amount
50,000,000 USD
Stage
Series A
series a
Investors
4
Provenance & confidence
High confidenceAmount
50,000,000 USD
ECB-at-date → €43M · rate 1.1712 on 2025-12-19
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Dec 2025
Round type
series a
Amount (EUR)
€43M